Selkoe D J
Department of Neurology, Harvard Medical School, and Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Ann N Y Acad Sci. 2000;924:17-25. doi: 10.1111/j.1749-6632.2000.tb05554.x.
A central challenge of research on Alzheimer's disease (AD) is to assemble the enormous body of scientific observations about the disorder, some of them seemingly in conflict with others, into a coherent and credible mechanism of pathogenesis. In this article, I attempt to synthesize the disparate findings on AD into a unified sequence that essentially begins with alterations in the production or clearance of the amyloid beta-protein (A beta). Mounting evidence from many laboratories supports an A beta accumulation in limbic and association cortices as the fundamental initiator of the disease, with attendant therapeutic implications.
阿尔茨海默病(AD)研究的一个核心挑战是,将有关该疾病的大量科学观察结果——其中一些似乎相互矛盾——整合为一个连贯且可信的发病机制。在本文中,我试图将关于AD的不同研究结果综合成一个统一的序列,该序列本质上始于淀粉样β蛋白(Aβ)产生或清除的改变。许多实验室越来越多的证据支持,边缘系统和联合皮质中Aβ的积累是该疾病的基本起始因素,并具有相应的治疗意义。